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Abstract
Advances in noninvasive imaging techniques such as magnetic resonance perfusion imaging have
been found useful in grading cerebral neoplasms and have potential for significant clinical benefit.
The purpose of this study was to determine the correlation between tumor vessel tortuosity as
measured from vessels extracted from magnetic resonance angiograms (MRA) and perfusion
parameters of cerebral blood flow (CBF) and cerebral blood volume (CBV) in intracranial neoplasms.
We hypothesized that tumor blood vessel tortuosity measures and perfusion measures would be
correlated, since both are increased by tumor angiogenesis. 18 patients with 19 cerebral neoplasms
were evaluated with conventional MR imaging and dynamic contrast-enhanced T2-weighted
perfusion MR imaging (PWI). Both benign and malignant lesions were included, as were hyper- and
hypovascular tumors. Regions of interest were plotted within the tumor area to locate foci of
maximum CBV and CBF. CBV and CBF measurements were also recorded in contralateral normal
appearing white matter to calculate relative CBV (rCBV) and relative CBF (rCBF). Vessel tortuosity
analyses were conducted upon vessels segmented from MRA images of the same patients using two
tortuosity descriptors (SOAM and ICM), which have previously been demonstrated to have efficacy
in separating benign from malignant disease. Linear regression analyses were conducted to determine
if correlations exist between CBV or CBF and the two tortuosity measurements. For the overall set
of tumors, no significant correlations were found between flow or volume measures and the tortuosity
measures. However, when the 7 glioblastoma multiforme tumors were examined as a subgroup, the
following significant correlations were found: rCBV and SOAM (R2=0.799), rCBV and ICM
(R2=0.214). Our results demonstrate that MR perfusion imaging data do not correlate significantly
with vessel tortuosity parameters as determined from the larger vessels seen by MRA. However, for
subgroups of a particular tumor type such as GBM, there may be significant correlations. It appears
that perfusion and tortuosity data may provide independently useful data in the assessment of cerebral
neoplasms.
Introduction
Advances in noninvasive imaging techniques such as perfusion MR imaging have been found
useful in grading cerebral neoplasms and have potential for significant clinical benefit (1–7).
An alternative approach is to analyze shape measures of the larger vessels seen by magnetic
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resonance angiography (MRA). This approach also has been shown to have potential for
discriminating between benign and malignant disease (8–10). In this study, we attempt to
determine the independent utility of perfusion MR imaging and the morphologic analysis of
the larger vessels visualized directly by MRA for evaluation of intracranial neoplasms.
The advantage of perfusion imaging is that it can provide information at the sub-voxel level.
The disadvantage of perfusion imaging is that it is restricted to analysis of blood flow and
volume, and both malignant and benign tumors may be either hypo- or hypervascular. An
assessment of malignancy based solely upon perfusion measures may therefore provide a
significant number of both false positives and false negatives (7).
Analysis of the larger vessels seen by MRA has complementary advantages and disadvantages.
The disadvantage of analysis of these larger vessels is that current levels of MRA resolution
preclude direct imaging of capillaries, and so important information may be missed. The
advantage of analyzing the larger vessels seen by MRA is that multiple shape measures can be
assessed in addition to that of blood vessel density. In particular, abnormal vessel tortuosity is
known to be associated with malignancy (11–13), Indeed, a prior blinded study aimed at
discriminating between benign and malignant tumors was successful in classifying all tumors
correctly based upon the tortuosity measurements of vessels defined from MRA and located
in the vicinity of each tumor (10).
The purpose of the current study is to investigate if there exists a correlation between cerebral
blood volume and flow with direct measurements of vessel tortuosity. This analysis would help
determine whether diagnostic workup of cerebral neoplasms is augmented by both macroscopic
vessel analysis and perfusion parameters of flow and volume. It is our hypothesis that tumor
blood vessel tortuosity measures and perfusion measures should be correlated, since both are
likely to increase as a result of tumor angiogenesis.
Materials and Methods
18 patients with 19 cerebral neoplasms (primary astrocytic brain neoplasms included
glioblastoma multiforme [7], low grade glioma [1], grade 3 anaplastic astrocytoma [1], and
grade 2 astrocytoma [1]; other neoplasms included metastases [6], pituitary adenoma [1],
lymphoma [1], and oligodendroglioma [1]) were evaluated with conventional MR imaging and
dynamic contrast-enhanced T2-weighted perfusion MR imaging (PWI). Images were obtained
on either a head-only 3T MR unit (Allegra, Siemens Medical Systems, Inc., Germany) or upon
a 1.5T MR unit (Sonata, Siemens Medical Systems Inc., Germany). A quadrature head coil
was employed. T1, T2, and MRA sequences were performed on all subjects.
A localizing sagittal T1-weighted image was obtained followed by non-enhanced axial T1-
weighted (600/14 [TR/TE]), axial fluid-attenuated inversion-recovery (FLAIR,
9000/110/2500 [TR/TE/TI]), and T2-weighted (3400/119) images. Contrast material-
enhanced axial T1-weighted imaging was performed after the acquisition of the perfusion MR
imaging data.
Dynamic contrast agent-enhanced T2-weighted gradient-echo echo-planar images were
acquired during the first pass of a standard dose (0.1 mmol/kg) bolus of gadopentalate
dimeglumine. (Magnevist; Berlex Laboratories, Wayne, NJ).
Vascular images employed a 3D time-of-flight MRA sequence. Our methods require
visualization of tiny vessels, voxels that are close to isotropic, and inclusion of the entire head.
Images were acquired using a protocol of 352 × 448 × 176 voxels and a voxel size of 0.5 × 0.5
× 0.8 mm3. Velocity compensation along both frequency and phase encoding directions was
used to minimize signal dephasing induced by the flowing spins. A magnetization transfer
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saturation pulse was applied to suppress signal from stationary brain parenchyma, augmenting
vascular contrast.
Image Processing: Large Vessels Seen by MRA
The approach is based upon a statistical analysis of blood vessel attributes (vessel shape and
density measures). For each tumor patient, a region of interest is defined. This region is usually
the tumor volume as seen by gadolinium-enhanced T1 images, but for tiny or avascular tumors
the region of interest is dilated until it includes a minimum of four vessels. This region of
interest is then mapped to the same patient’s MRA as well as to the MRAs of 17 healthy
subjects. Multiple measures of vessel shape are then calculated for all subjects within the
corresponding region of interest, and the tumor patient’s values are normalized via z-score by
the means and standard deviations of the values obtained from the healthy subjects. This
approach requires: i) a method of vessel definition, ii) a method of tumor definition, iii) a
method of aligning (registering) images, and iv) a set of methods to define significant vessel
attributes.
Vessel segmentation was done by Aylward’s method (14). Vessel extraction involves 3 steps:
definition of a seed point, automatic extraction of an image intensity ridge representing the
vessel’s central skeleton, and automatic determination of vessel radius at each skeleton point.
The output of the program provides sets of directed, 4-dimensional points indicating the (x,y,z)
spatial position of each sequential vessel skeleton point and an associated radius at each point.
Extracted vessels were then post-processed to produce connected vessel trees and to exclude
noise (15).
Tumor segmentation was performed using either a fully automated method (16) or a partially
manual program that segments tumors via polygon drawing and filling on orthogonal cuts
through an image volume (www.cs.unc.edu/~gerig/).
All images were registered via a mutual-information based, affine transformation (17,18) into
the coordinate system of the McConnell atlas (19) so that, via a combination of forward and
backward mapping, the same region of interest could be defined within each image. For each
tumor patient, vessels were automatically clipped to the tumor margins and an automated
analysis of vessel shape was performed only upon those vessels lying within the tumor
boundaries. This same region of interest was then mapped into the coordinate space of each
healthy patient, and a similar, regional analysis was performed upon each healthy subject’s
vasculature.
For purposes of malignancy classification based upon vessel shape measures, we have found
tortuosity determination to be the most important factor (10). We have previously described
two tortuosity measures (9). The “Sum of Angles Metric” (SOAM) sums total curvature along
a space curve and normalizes by path length. The SOAM is effective in detecting high-
frequency, low-amplitude sine waves or coils. The “Inflection Count Metric” (ICM) counts
minima of curvature along a space curve and then multiplies this number (plus 1) times the
total path length and divides by the distance between endpoints. The ICM is effective in
detecting vessels in an abnormal “bag of worms” configuration. Malignant tumor vessels
almost invariably exhibit abnormalities detectable by SOAM and, if foci of detectable
Image Processing: Perfusion Measures
For the CBF and CBV data, regions of interest (ROI) were plotted within the tumor area to
locate foci of maximum flow and volume. CBV and CBF measurements were also recorded
in contralateral normal appearing white matter to calculate relative CBV (rCBV) and relative
CBF (rCBF). The methods for acquiring perfusion data from a set of dynamic contrast-
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enhanced echo-planar images and the precise algorithm for calculating rCBV and rCBF have
been previously described (1).
Analysis—Linear regression analyzes were conducted to determine if correlations exist
between CBV or CBF and the two parameters used to measure the shapes of the larger vessels
seen directly by MRA.
Results
CBF, CBV and vessel tortuosity parameters of SOAM and ICM were collected for 19 tumors.
Correlation analysis results of CBF, CBV and the tortuosity parameters are shown in Table I.
No significant correlations were found between flow or volume measures and the two tortuosity
parameters (Table I). Subgroup analyzes were also conducted to examine the primary astrocytic
neoplasms; however, no significant correlations were found. When examining the glioblastoma
multiforme tumors as a subgroup, however, the following significant correlations were found:
rCBV and SOAM (R2=0.799), rCBV and ICM (R2=0.214). Figure 1(a–d) illustrates the linear
correlations between the perfusion and tortuosity parameters.
Analyzing the distribution of nlCBF, nlCBV, SOAM, and ICM stratified by tumor grade
(benign, low, high) was also informative. With respect to nlCBV, the high grade tumors as a
group had a higher mean value than the low grade group. It is interesting to note that the benign
group had a mean similar to the high grade group. This is not a surprising finding as benign
tumors such as meningiomas are known to have high flow and volume. With respect to nlCBF,
the high grade group has a higher mean value than the low grade group. The benign group had
a mean value approximately equal to the low grade group. With respect to SOAM, the benign
group had the highest mean value followed by approximately equal mean values for the low
and high grade groups. For ICM, the high grade group had the highest mean value. The low
grade group had the lowest value while the benign group was intermediate.
Discussion
Grading of cerebral neoplasms with noninvasive diagnostic imaging techniques has potential
for significant clinical benefit. To date however, it has yet to be demonstrated as a reliable
process with high sensitivity and specificity. Although noninvasive imaging approaches to
detect malignancy have included positron emission tomography, and magnetic resonance (MR)
spectroscopy, perfusion MR, and diffusion weighted MR images, as well as various image
processing methods, a single method has yet to be proven fully reliable in differentiating benign
from malignant disease (24–32).
In evaluating cerebral neoplasms, especially gliomas, there are significant limitations
associated with histopathologic grading. There is inherent sampling error associated with
stereotactic biopsy and also the inability to properly evaluate residual tumor tissue after
cryoreductive surgery (33). The advantage of novel MR imaging techniques in evaluating
cerebral neoplasms is the ability to sample not only the entire lesion, but also the adjacent tissue
for physiologic changes.
Conventional MR imaging with contrast agents is already an established, useful tool in
characterization of cerebral tumors, especially in terms of anatomy and morphology (34–38).
However, in terms of classifying and grading tumors with optimization sequences and
protocols, no method has proven to be very reliable. The sensitivity for glioma grading has
been shown to range from 55.1% to 83.3% (1,39–42). Much of this reduced sensitivity is due
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to the fact that not all high grade lesions manifest with the typical characteristics of contrast
enhancement, edema, hemorrhage, necrosis, and/or mass effect.
Dean et al. demonstrated that the two most important predictors of tumor grade are mass effect
and necrosis (43). The dilemma lies in the situation when a high grade glioma is mistaken for
being low grade due to minimal edema, no contrast enhancement, no necrosis, and no mass
effect. On the other hand, low-grade gliomas can be mistaken for being high grade due to
peritumoral edema, contrast enhancement, central necrosis, and mass effect. Several studies
have demonstrated that contrast material enhancement alone is not always accurate in
predicting tumor grade (44–46). Also, when using conventional T2-weighted MR images, the
peritumoral hyperintensity is nonspecific as it may represent vasogenic edema, tumor
infiltration, or both. Moreover, conventional MR imaging does not provide reliable information
on tumor physiology which is a significant factor in determining tumor grade.
Recently, advanced imaging techniques such as perfusion MR imaging and proton MR
spectroscopy have been found useful in studying brain tumors. Specifically, relative cerebral
blood volume (rCBV) maps and measurements have been shown to correlate with tumor grade
and histologic findings of increased tumor vascularity (20–23). It is plausible that physiological
measurements such as blood volume and flow would assist in predicting tumor grade. Despite
the widespread interest in characterization of neoplasms with perfusion MR imaging, the
current clinical role of CBV and CBF (cerebral blood flow) requires further investigation.
In addition to the parameters of blood flow and volume, another characteristic of interest is
vessel tortuosity. It has been demonstrated in previous studies that neoangiogenesis associated
with malignancy often results in vessels distinguished by a tortuous shape (11–13). This
observation led to investigation of whether high-resolution MRA analysis of vessel shape could
be used for noninvasive diagnosis of malignancy.
Discrete definition of vessel paths is key in studying vessel tortuosity. The most common
approach to visualizing vessels in 3D is by maximum intensity projection, which allows
inspection of a block of data from any point of view. Previous investigators have proposed
methods of mathematically defining vessels from 3D image data (47). In the approach from
our institution, the advantage is definition of very small vessels without significant noise
interference. The exact meaning of vessel tortuosity is not standard by any means. A recent
proposed classification scheme of “abnormal tortuosity” is comprised of three different patterns
(9). Tortuosity type I occurs when a straight vessel elongates to form a “C” or “S”, and occurs
with retinopathy of prematurity, anemia, and hypertension. Tortuosity type II is characterized
by a “can of worms” configuration, and occurs within many hypervascular lesions. Tortuosity
type III is characterized by high-frequency, low-amplitude coils or sine waves, and appears
within malignant tumors.
This report provides insight into two novel noninvasive methods of determining tumor
malignancy. Both methods have previously been described in separate reports to be significant
predictors of tumor grade and to augment conventional diagnostic imaging techniques. We
specifically intended to study whether there exists a correlation between the MR perfusion
parameters of CBF and CBV and the parameters of vessel tortuosity analysis. Our premise was
that if both parameters are correlated, then one method would suffice as part of the diagnostic
workup of cerebral neoplasms. Our results demonstrate that the MR perfusion imaging data
do not correlate significantly with vessel tortuosity parameters. This may be due to the fact
that tortuosity does not depend on vessel density. However when stratified by grade, the high
grade tumors in our study had higher mean values with respect to nlCBF, nlCBV, SOAM, and
ICM than the low grade tumors. For subgroups of tumors such as GBM, there may be significant
correlations and further investigation with larger sample size would need to be undertaken to
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determine this. Overall, it appears that the perfusion and tortuosity data may both provide
independently useful data in the assessment of cerebral neoplasms.
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Linear correlations between (a) normalized cerebral blood flow (nlCBF) and the vessel
tortuosity parameter Sum of Angles Metric (SOAM); (b) nlCBF and the vessel tortuosity
parameter Inflection Count Metric (ICM); (c) normalized cerebral blood volume (nlCBV) and
SOAM; (d) nlCBV and ICM are shown. Correlation coefficients are given. hypervascularity
are present, will also exhibit abnormalities detectable by the ICM. More information on the
mathematical definition of these measures is found in (9).
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Table I
SOAM ICM
rCBV R2=0.0118 (p=0.658) R2=0.1402 (p=0.114)
rCBF R2=0.1094 (p=0.167) R2=0.0241 (p=0.526)
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